QS Investors’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $243K | Sell |
35,700
-700
| -2% | -$4.77K | ﹤0.01% | 1008 |
|
|
2021
Q1 | $374K | Buy |
36,400
+17,000
| +88% | +$175K | ﹤0.01% | 903 |
|
|
2020
Q4 | $136K | Hold |
19,400
| – | – | ﹤0.01% | 1127 |
|
|
2020
Q3 | $159K | Sell |
19,400
-81,500
| -81% | -$668K | ﹤0.01% | 1095 |
|
|
2020
Q2 | $697K | Hold |
100,900
| – | – | 0.01% | 830 |
|
|
2020
Q1 | $480K | Hold |
100,900
| – | – | 0.01% | 852 |
|
|
2019
Q4 | $878K | Sell |
100,900
-1,500
| -1% | -$13.1K | 0.01% | 813 |
|
|
2019
Q3 | $341K | Hold |
102,400
| – | – | ﹤0.01% | 1052 |
|
|
2019
Q2 | $507K | Sell |
102,400
-2,300
| -2% | -$11.4K | 0.01% | 968 |
|
|
2019
Q1 | $650K | Buy |
104,700
+103,300
| +7,379% | +$641K | 0.01% | 922 |
|
|
2018
Q4 | $5K | Buy |
+1,400
| New | +$5K | ﹤0.01% | 1581 |
|